Clinical efficacy of inferior peripheral irido-capsulo-hyaloidotomy for pseudophakic malignant glaucoma.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 03 01 2020
accepted: 12 05 2021
pubmed: 1 6 2021
medline: 18 8 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

The present research aimed to investigate the effects of Inferior peripheral irido-capsulo-hyaloidotomy for the management of pseudophakic malignant glaucoma. Ten pseudophakic eyes with aqueous misdirection were diagnosed between September 2017 and December 2018 (10 eyes of 8 patients), which were included in the prospective consecutive case series study. Seven eyes underwent Inferior laser peripheral irido-capsulo-hyaloidotomy, and three eyes underwent pars plana vitrectomy, zonulo-capsulo-hyaloidectomy, and inferior iridectomy. Eight eyes (80%) had angle-closure glaucoma. The mean duration of the follow-up was 12.25 ± 3.05 months (ranging from 10-18 months). The patients had a mean age of 69.25 ± 6 years. The IOP at the onset of malignant glaucoma was found to be 33.8 ± 5.5 mmHg, which was reduced to 13.9 ± 2.7 mmHg at the final visit (P value = 0.002). The reduction in the number ± SD of anti-glaucoma medications (3.3 ± 0.48 to 1.4 ± 0.51) and improvement in mean ± SD LogMAR visual acuity (1.2 ± 0.06 to 0.61 ± 0.26) between the onset and final visit were significant (p = 0.004 and P = 0.005, respectively). All the patients responded to Inferior peripheral irido-capsulo-hyaloidotomy (with YAG laser or with the surgical procedure), which led to a significant reduction in intraocular pressure (IOP) and deepening of the anterior chamber. The success rate of peripheral irido-capsulo-hyaloidotomy with laser or surgical procedure in the inferior quadrant was high regarding pseudophakic malignant glaucoma patients. The establishment of a patent inferior communication between the vitreous cavity and the anterior chamber was the main component in the treatment of pseudophakic malignant glaucoma patients.

Identifiants

pubmed: 34056702
doi: 10.1007/s10792-021-01880-4
pii: 10.1007/s10792-021-01880-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3153-3161

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Moinul P, Hutnik CML (2015) Aqueous misdirection syndrome: an interesting case presentation. Clin Ophthalmol 9:183–186
doi: 10.2147/OPTH.S75698
Grzybowski A, Kanclerz P (2018) Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefes Arch Clin Exp Ophthalmol 256(1):135–154.
doi: 10.1007/s00417-017-3837-0
Burgansky-Eliash Z, Ishikawa H, Schuman JS (2008) Hypotonous malignant glaucoma: aqueous misdirection with low intraocular pressure. Ophthalmic Surg Lasers Imaging 39:155–159
doi: 10.3928/15428877-20080301-03
Ng WT, Morgan W (2012) Mechanisms and treatment of primary angle closure: a review. Clin Exp Ophthalmol 40(4):e218–e228
doi: 10.1111/j.1442-9071.2011.02604.x
Dave P, Senthil S, Rao HL, Garudadri CS (2013) Treatment outcomes in malignant glaucoma. Ophthalmology 120:984–990
doi: 10.1016/j.ophtha.2012.10.024
Sharma A, Sii F, Shah P, Kirkby GR (2006) Vitrectomy–phacoemulsification–vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology 113:1968–1973
doi: 10.1016/j.ophtha.2006.04.031
Debrouwere VS, Van Calster J, Spileers W, Zeyen T, Stalmans I (2012) Outcomes of different management options for malignant glaucoma: a retrospective study. Graefes Arch Clin Exp Ophthalmol 250(1):131–141
doi: 10.1007/s00417-011-1763-0
Balekudaru S, Choudhari NS, Rewri P, George R, Bhende PS, Bhende M, Lingam V, Lingam G (2017) Surgical management of malignant glaucoma: a retrospective analysis of fifty eight eyes. Eye (lond) 31(6):947–955
doi: 10.1038/eye.2017.32
Shahid H, Salmon JF (2012) Malignant glaucoma: a review of the modern literature. J Ophthalmol 2012:852659
doi: 10.1155/2012/852659
González-Martín-Moro J, Iglesias-Ussel L, Cobo-Soriano R, Fernández-Miguel Y, Contreras I (2019) Spontaneous malignant glaucoma: Case report and review of the literature. Saudi J Ophthalmol 33(4):398–400
doi: 10.1016/j.sjopt.2018.11.005
Zarnowski T, Rękas M (2014) Efficacy and safety of a new surgical method to treat malignant glaucoma in pseudophakia: reply. Eye 28:1391–1392
doi: 10.1038/eye.2014.188
Prata TS, Dorairaj S, De Moraes CGV, Mehta S, Sbeity Z, Tello C, Liebmann J, Ritch R (2013) Is preoperative ciliary body and iris anatomical configuration a predictor of malignant glaucoma development? Clin Exp Ophthalmol 41:541–545
doi: 10.1111/ceo.12057
Krix-Jachym K, Żarnowski T, Rękas M (2017) Risk factors of malignant glaucoma occurrence after glaucoma surgery. J Ophthalmol 2017:9616738
doi: 10.1155/2017/9616738
de Preobrajensky N, Mrejen S, Adam R, Ayello-Scheer S, Gendron G, Rodallec T, Sahel J-A, Barale P-O (2010) 23-gauge transconjunctival sutureless vitrectomy: a retrospective study of 164 consecutive cases. J Fr Ophtalmol 33:99–104
doi: 10.1016/j.jfo.2009.12.006
Rekas M, Krix-Jachym K, Zarnowski T (2015) Evaluation of the effectiveness of surgical treatment of malignant glaucoma in pseudophakic eyes through partial PPV with establishment of communication between the anterior chamber and the vitreous cavity. J Ophthalmol 2015:873124
doi: 10.1155/2015/873124
Hosada Y, Akagi T, Yoshimura N (2014) Two cases of malignant glaucoma unresolved by pars plana vittrectomy. Clin Ophthalmol 8:677–679
Su X, Vesco C, Fleming J, Choh V (2009) Density of ocular components of the bovine eye. Optom Vis Sci 86(10):1187–1195
doi: 10.1097/OPX.0b013e3181baaf4e

Auteurs

Afsaneh Naderi Beni (A)

Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University Medical Sciences, Isfahan, Iran. a_naderibeni@yahoo.com.
Ophthalmology Department, Isfahan Eye Research Center, Feiz Hospital, Modares Street, Isfahan, Iran. a_naderibeni@yahoo.com.

Hamid Fesharaki (H)

Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University Medical Sciences, Isfahan, Iran.

Heshmatollah Ghanbari (H)

Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University Medical Sciences, Isfahan, Iran.

Farzan Kianersi (F)

Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University Medical Sciences, Isfahan, Iran.

Fariba Naderi Beni (F)

Department of Laboratory, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Batool Naderi Beni (B)

Department of Basic Science, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH